Eeg Disposable Medical Electrodes Market Professional Survey Research Forecast Report 2023-2030

Pharmaceuticals
Sachin CMI's picture

The EEG disposable medical electrodes market is estimated to be valued at US$ 736.6 Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. 

Market Overview: 

EEG disposable medical electrodes are primarily used in electroencephalography (EEG) procedures for recording patients' brain wave signals. These electrodes help neurologists monitor and diagnose brain disorders and health conditions such as epilepsy, brain injury, dementia, sleep disorders, and strokes. EEG disposable electrodes are available in different shapes and sizes depending on the area of placement and application. Their disposable nature prevents cross-contamination between patients.

Read More Insights @ https://www.coherentmarketinsights.com/market-insight/eeg-disposable-medical-electrodes-market-3821

Market Dynamics:

The global EEG disposable medical electrodes market is primarily driven by the growing prevalence of neurological and brain-related disorders. According to the WHO, over 50 million people worldwide have epilepsy. Additionally, an estimated 50 million people have Alzheimer's disease or dementia. The rising cases of neurological conditions are expected to fuel the demand for EEG procedures and in turn boost the market growth for disposable medical electrodes. Furthermore, technological advancements in EEG equipment with improved connectivity and digital monitoring capabilities are also accelerating the adoption of disposable electrodes. However, budgetary constraints in certain economies may negatively impact market expansion during the forecast period.

SWOT Analysis 

Strength: EEG disposable medical electrodes have quick setup time, stable signal acquisition and high patient comfort. They offer consistent and accurate EEG recordings for neurophysiological diagnoses. These dry-contact electrodes reduce preparation time compared to wet gel-based alternatives. 

Weakness: EEG disposable medical electrodes have limited usage as they are meant for single-time use. They cannot be reused which increases recurring costs for hospitals and healthcare facilities. Adhesion issues may also occur in certain cases.

Opportunity: Rising incidence of neurological disorders along with increasing acceptance of ambulatory EEG monitoring presents an opportunity for EEG disposable medical electrodes market. Growing healthcare expenditure in emerging nations also provides growth prospects. 

Threats: Presence of substitute technologies like wet gel-based electrodes and emerging dry electrode systems poses competition to EEG disposable medical electrodes. Stringent regulatory approval process and pricing pressure from large buyers also threatens market growth.

Key Takeaways 

The global EEG disposable medical electrodes market is expected to witness high growth, exhibiting CAGR of 4.4% over the forecast period, due to increasing incidence of neurological disorders, growing geriatric population, and rising demand for ambulatory EEG monitoring. 

The North America region currently dominates the market owing to large patient base, supportive reimbursement policies, and technological advancements. Asia Pacific is expected to be the fastest growing market for EEG disposable medical electrodes driven by increasing healthcare spending, expanding medical infrastructure and growing awareness.

Key players operating in the EEG disposable medical electrodes market are Medtronic Plc, 3M, Ambu A/S, GE Healthcare, Johnson & Johnson, Nissha GSI Technologies, Olympus Corporation, Conmed Corporation, Graphic Controls, Yancheng Tianrun Medical Technology Co., Ltd., B. Braun Melsungen AG, Stryker Corporation, Utah Medical Products, Inc., ZOLL Medical Corporation, Symmetry Surgical, Brain Scientific, Inc., Rhythmlink International, Erbe Elektromedizin GmbH, KLS Martin Group, Screentec Oy, Nihon Kohden Corporation, IMAC Holdings, Inc., Natus Medical Incorporated, and Koninklijke Philips N.V.